Colorectal Cancer Screening in Average Risk Populations: Evidence Summary

Introduction. The objectives of this systematic review were to evaluate the evidence for different CRC screening tests and to determine the most appropriate ages of initiation and cessation for CRC screening and the most appropriate screening intervals for selected CRC screening tests in people at a...

Full description

Bibliographic Details
Main Authors: Jill Tinmouth, Emily T. Vella, Nancy N. Baxter, Catherine Dubé, Michael Gould, Amanda Hey, Nofisat Ismaila, Bronwen R. McCurdy, Lawrence Paszat
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2016/2878149
id doaj-b79d1e8dae3c4894b5aa5f094734f3b1
record_format Article
spelling doaj-b79d1e8dae3c4894b5aa5f094734f3b12020-11-25T00:44:58ZengHindawi LimitedCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972016-01-01201610.1155/2016/28781492878149Colorectal Cancer Screening in Average Risk Populations: Evidence SummaryJill Tinmouth0Emily T. Vella1Nancy N. Baxter2Catherine Dubé3Michael Gould4Amanda Hey5Nofisat Ismaila6Bronwen R. McCurdy7Lawrence Paszat8Prevention and Cancer Control, Cancer Care Ontario, Toronto, ON, CanadaProgram in Evidence-Based Care, Cancer Care Ontario, Hamilton, ON, CanadaPrevention and Cancer Control, Cancer Care Ontario, Toronto, ON, CanadaPrevention and Cancer Control, Cancer Care Ontario, Toronto, ON, CanadaWilliam Osler Health Centre, Etobicoke, ON, CanadaNortheast Cancer Centre Health Sciences North/Horizon Santé-Nord, Sudbury Outpatient Centre, Sudbury, ON, CanadaAmerican Society of Clinical Oncology, Alexandria, VA, USAPrevention and Cancer Control, Cancer Care Ontario, Toronto, ON, CanadaDepartment of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, CanadaIntroduction. The objectives of this systematic review were to evaluate the evidence for different CRC screening tests and to determine the most appropriate ages of initiation and cessation for CRC screening and the most appropriate screening intervals for selected CRC screening tests in people at average risk for CRC. Methods. Electronic databases were searched for studies that addressed the research objectives. Meta-analyses were conducted with clinically homogenous trials. A working group reviewed the evidence to develop conclusions. Results. Thirty RCTs and 29 observational studies were included. Flexible sigmoidoscopy (FS) prevented CRC and led to the largest reduction in CRC mortality with a smaller but significant reduction in CRC mortality with the use of guaiac fecal occult blood tests (gFOBTs). There was insufficient or low quality evidence to support the use of other screening tests, including colonoscopy, as well as changing the ages of initiation and cessation for CRC screening with gFOBTs in Ontario. Either annual or biennial screening using gFOBT reduces CRC-related mortality. Conclusion. The evidentiary base supports the use of FS or FOBT (either annual or biennial) to screen patients at average risk for CRC. This work will guide the development of the provincial CRC screening program.http://dx.doi.org/10.1155/2016/2878149
collection DOAJ
language English
format Article
sources DOAJ
author Jill Tinmouth
Emily T. Vella
Nancy N. Baxter
Catherine Dubé
Michael Gould
Amanda Hey
Nofisat Ismaila
Bronwen R. McCurdy
Lawrence Paszat
spellingShingle Jill Tinmouth
Emily T. Vella
Nancy N. Baxter
Catherine Dubé
Michael Gould
Amanda Hey
Nofisat Ismaila
Bronwen R. McCurdy
Lawrence Paszat
Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
Canadian Journal of Gastroenterology and Hepatology
author_facet Jill Tinmouth
Emily T. Vella
Nancy N. Baxter
Catherine Dubé
Michael Gould
Amanda Hey
Nofisat Ismaila
Bronwen R. McCurdy
Lawrence Paszat
author_sort Jill Tinmouth
title Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
title_short Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
title_full Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
title_fullStr Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
title_full_unstemmed Colorectal Cancer Screening in Average Risk Populations: Evidence Summary
title_sort colorectal cancer screening in average risk populations: evidence summary
publisher Hindawi Limited
series Canadian Journal of Gastroenterology and Hepatology
issn 2291-2789
2291-2797
publishDate 2016-01-01
description Introduction. The objectives of this systematic review were to evaluate the evidence for different CRC screening tests and to determine the most appropriate ages of initiation and cessation for CRC screening and the most appropriate screening intervals for selected CRC screening tests in people at average risk for CRC. Methods. Electronic databases were searched for studies that addressed the research objectives. Meta-analyses were conducted with clinically homogenous trials. A working group reviewed the evidence to develop conclusions. Results. Thirty RCTs and 29 observational studies were included. Flexible sigmoidoscopy (FS) prevented CRC and led to the largest reduction in CRC mortality with a smaller but significant reduction in CRC mortality with the use of guaiac fecal occult blood tests (gFOBTs). There was insufficient or low quality evidence to support the use of other screening tests, including colonoscopy, as well as changing the ages of initiation and cessation for CRC screening with gFOBTs in Ontario. Either annual or biennial screening using gFOBT reduces CRC-related mortality. Conclusion. The evidentiary base supports the use of FS or FOBT (either annual or biennial) to screen patients at average risk for CRC. This work will guide the development of the provincial CRC screening program.
url http://dx.doi.org/10.1155/2016/2878149
work_keys_str_mv AT jilltinmouth colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT emilytvella colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT nancynbaxter colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT catherinedube colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT michaelgould colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT amandahey colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT nofisatismaila colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT bronwenrmccurdy colorectalcancerscreeninginaverageriskpopulationsevidencesummary
AT lawrencepaszat colorectalcancerscreeninginaverageriskpopulationsevidencesummary
_version_ 1725272170595090432